Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's planned introduction of two generic loratadine formulations in early 2004 is expected to improve the firm's lackluster cough/cold sales in the second half of its fiscal year